Drug intelligence / Profile preview

acitretin

Development stage
Approved
Lead developer
AbbVie
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Acitretin is an oral retinoid (vitamin A derivative) used primarily to treat severe forms of psoriasis and other disorders of keratinization in adults who have not responded to standard treatments. It works by normalizing the growth and differentiation of skin cells, thereby reducing the abnormal proliferation seen in conditions like psoriasis. Acitretin is a metabolite of etretinate and is considered more manageable due to its shorter half-life. The exact mechanism by which it improves skin disorders is not fully understood but involves modulation of gene expression through retinoic acid receptors, leading to decreased epidermal cell proliferation and inflammation. Acitretin carries significant teratogenic risk; strict pregnancy prevention measures are required during treatment and for at least 2–3 years after discontinuation due to its long elimination time[1][2][5][7].

Brand names
SoriataneNeotigasonNovatretin
Other names
阿维Aacitretina (Spanish)acitretyna (Polish)
02

Targets

RXRA (Retinoid X receptor alpha)RARA (Retinoic acid receptor alpha)

Beyond the preview

Go deeper on acitretin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acitretin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call